DK1729735T3 - Fremgangsmåde til fremstilling af sammenpressede, faste doseringsformer, som er velegnede til brug sammen med lægemidler med lav vandoplöselighed og sammenpressede, faste doseringsformer fremstillet derved - Google Patents

Fremgangsmåde til fremstilling af sammenpressede, faste doseringsformer, som er velegnede til brug sammen med lægemidler med lav vandoplöselighed og sammenpressede, faste doseringsformer fremstillet derved

Info

Publication number
DK1729735T3
DK1729735T3 DK04810659T DK04810659T DK1729735T3 DK 1729735 T3 DK1729735 T3 DK 1729735T3 DK 04810659 T DK04810659 T DK 04810659T DK 04810659 T DK04810659 T DK 04810659T DK 1729735 T3 DK1729735 T3 DK 1729735T3
Authority
DK
Denmark
Prior art keywords
dosage forms
solid dosage
compressed solid
preparation
water solubility
Prior art date
Application number
DK04810659T
Other languages
English (en)
Inventor
Ilan Zalit
Fanny Leska
Mali Kadosh
Dorit Marco
Yonit Messer-Triger
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of DK1729735T3 publication Critical patent/DK1729735T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK04810659T 2004-11-10 2004-11-10 Fremgangsmåde til fremstilling af sammenpressede, faste doseringsformer, som er velegnede til brug sammen med lægemidler med lav vandoplöselighed og sammenpressede, faste doseringsformer fremstillet derved DK1729735T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/037462 WO2006052254A2 (en) 2004-11-10 2004-11-10 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

Publications (1)

Publication Number Publication Date
DK1729735T3 true DK1729735T3 (da) 2007-10-08

Family

ID=36218312

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04810659T DK1729735T3 (da) 2004-11-10 2004-11-10 Fremgangsmåde til fremstilling af sammenpressede, faste doseringsformer, som er velegnede til brug sammen med lægemidler med lav vandoplöselighed og sammenpressede, faste doseringsformer fremstillet derved

Country Status (11)

Country Link
EP (1) EP1729735B1 (da)
JP (1) JP4842960B2 (da)
AT (1) ATE365546T1 (da)
AU (1) AU2004324858B2 (da)
CA (1) CA2587295A1 (da)
DE (1) DE602004007302T2 (da)
DK (1) DK1729735T3 (da)
HK (1) HK1096875A1 (da)
IL (2) IL182549A (da)
PT (1) PT1729735E (da)
WO (1) WO2006052254A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2242483B1 (en) * 2007-12-21 2013-02-20 Synthon B.V. Raloxifene composition
US20110159084A1 (en) * 2008-04-02 2011-06-30 Dr. Reddy's Laboratories Ltd. Raloxifene pharmaceutical formulations
EP2448562B1 (en) 2009-07-02 2013-11-06 Synthon B.V. Raloxifene composition
EP3650010B1 (en) * 2018-11-09 2021-01-06 Siegfried AG Improved tableting process

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
AU701042B2 (en) * 1995-02-28 1999-01-21 Aventisub Llc Pharmaceutical composition for piperidinoalkanol compounds
IL115357A (en) * 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
IL153441A0 (en) * 2000-06-16 2003-07-06 Teva Pharma Stable gabapentin having ph within a controlled range
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
US20040185097A1 (en) * 2003-01-31 2004-09-23 Glenmark Pharmaceuticals Ltd. Controlled release modifying complex and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
DE602004007302T2 (de) 2008-03-20
DE602004007302D1 (de) 2007-08-09
AU2004324858B2 (en) 2009-12-10
JP2008519834A (ja) 2008-06-12
HK1096875A1 (en) 2007-06-15
EP1729735B1 (en) 2007-06-27
IL182549A (en) 2010-11-30
IL182549A0 (en) 2007-09-20
EP1729735A2 (en) 2006-12-13
JP4842960B2 (ja) 2011-12-21
WO2006052254A2 (en) 2006-05-18
WO2006052254A3 (en) 2006-08-17
PT1729735E (pt) 2007-08-06
CA2587295A1 (en) 2006-05-18
ATE365546T1 (de) 2007-07-15
AU2004324858A1 (en) 2006-05-18
IL200447A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
WO2004056363A3 (en) A physically and chemically stable nicotine-containing particulate material
WO2009043844A3 (en) Orodispersible tablets
RU2008116316A (ru) Новый состав
MY151468A (en) Controlled release solid preparation
WO2004012700A3 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
RU2008106220A (ru) Гастроретентивные композиции и способ их изготовления
WO2004050058A3 (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
NZ527585A (en) Tablets quickly disintegrated in oral cavity
WO2006100281A3 (en) Solubilized ibuprofen
AR062509A1 (es) Proceso para preparar comprimidos de dihidrocloruro de pramipexol
HK1072359A1 (en) Pharmaceutical composition comprising N-((1-N-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-A)indole-10carboxamide or salt and process for preparing thereof comprising dry granulation
RS50937B (sr) Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii
WO2009038112A1 (ja) Ｎｐｙｙ５受容体拮抗剤を含有する固形製剤
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
UA96622C2 (ru) Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования
WO2008100240A3 (en) Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
RU2016117186A (ru) Комбинированная композиция, содержащая тадалафил и амлодипин
IL200447A0 (en) Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
EA200500671A1 (ru) Фармацевтический состав оланзапина
WO2007010369B1 (en) Sustained release formulation of alprazolam
RU2007133793A (ru) Составы с контролируемым высвобождением альфузозина